Lumefantrine Unknown Status Phase 4 Trials for Anemia / schistosoma infection / Change in Sustained Attention / Plasmodium Infections / Helminthiasis Prevention

IndicationsStatusPurposePhase
Unknown StatusPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01459146Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana